Marc Uknis to Cytomegalovirus Infections
This is a "connection" page, showing publications Marc Uknis has written about Cytomegalovirus Infections.
Connection Strength
0.964
-
Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME. Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant. 2007 Mar-Apr; 21(2):149-58.
Score: 0.266
-
Uknis ME. Prophylaxis of cytomegalovirus disease in transplant patients. Am J Health Syst Pharm. 2005 Apr 15; 62(8 Suppl 1):S3-6.
Score: 0.234
-
Maertens J, Cordonnier C, Jaksch P, Poir? X, Uknis M, Wu J, Wijatyk A, Saliba F, Witzke O, Villano S. Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation. N Engl J Med. 2019 09 19; 381(12):1136-1147.
Score: 0.159
-
Papanicolaou GA, Silveira FP, Langston AA, Pereira MR, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M, Marty FM, Villano S. Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. Clin Infect Dis. 2019 04 08; 68(8):1255-1264.
Score: 0.154
-
Pavlakis M, Khwaja K, Mandelbrot D, Tang H, Whiting JW, Lorber MI, Gautam A, Johnson SR, Uknis ME. Renal allograft failure predictors after PAK transplantation: results from the New England Collaborative Association of Pancreas Programs. Transplantation. 2010 Jun 15; 89(11):1347-53.
Score: 0.084
-
Weng FL, Patel AM, Wanchoo R, Brahmbhatt Y, Ribeiro K, Uknis ME, Mulgaonkar S, Mathis AS. Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants. Transplantation. 2007 Feb 15; 83(3):290-6.
Score: 0.066